Indraprastha Medical Corporation bulk deals and stake changes
NSE: INDRAMEDCOBSE: 532150Healthcare ServicesSmall Cap
Last close ₹299.80down ₹5.80 (1.90%)BSE ₹299.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹305.60.
52-week range of traded prices to 23 Oct 2026
₹293.65Low, 23 Oct 2026₹640.85High, 6 Nov 2025
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,748 Cr899th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 14.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 3.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.33%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 28.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 30.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,27,11961.6% delivered
Indraprastha Medical Corporation stake sales and purchases
All 4 disclosures on record.
Apr 2024
- SoldHDFC Bank Limited3.03% of the company27,81,897 sharesholds 2.45% after4 Apr 2024 · filed under the 2% rule · Open Market
Feb 2024
- SoldHDFC Bank Ltd0.49% of the company20,23,683 sharesholds 5.49% after28 Feb 2024 · filed under the 2% rule · Open Market
Jul 2023
- AcquiredHDFC Bank Limited6.71% of the company61,46,897 sharesholds 6.71% after1 Jul 2023 · filed under the 5% rule
Dec 2015
- SoldHOUSING DEVELOPMENT FINANCE CORPORATION LTD2.12% of the company19,44,420 sharesholds 7.69% after24 Dec 2015 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Indraprastha Medical Corporation bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 8 Oct 20251 firm · ₹72 Cr bought · ₹72 Cr soldNet bought ₹0.04 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 12,32,834 at ₹587.07Sold 12,32,350 at ₹586.981.34% of the companyNet +484 shares₹72 Cr bought
Tuesday 7 Oct 20251 firm · ₹27 Cr bought · ₹0.48 Cr soldNet bought ₹27 Cr
- Both waysSWAY FINANCIAL SERVICESBought 4,87,634 at ₹555.26Sold 9,294 at ₹512.530.53% of the companyNet +4,78,340 shares₹27 Cr bought
Wednesday 7 Aug 20241 firm · ₹18 Cr bought · ₹18 Cr soldNet sold ₹0.02 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 5,41,765 at ₹327.06Sold 5,41,765 at ₹327.420.59% of the companyNet nil₹18 Cr bought
Monday 22 Apr 20241 firm · ₹14 Cr bought · ₹0 soldNet bought ₹14 Cr
- BoughtQUANT MUTUAL FUND - QUANT SMALL CAP FUNDBought 5,50,000 at ₹249.590.60% of the company₹14 Cr
Wednesday 9 Jun 20211 firm · ₹7.06 Cr bought · ₹7.06 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 7,07,868 at ₹99.69Sold 7,07,868 at ₹99.690.77% of the companyNet nil₹7.06 Cr bought
Monday 7 Jun 20211 firm · ₹4.67 Cr bought · ₹4.67 Cr soldNet sold ₹53,220
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,83,819 at ₹96.45Sold 4,83,819 at ₹96.560.53% of the companyNet nil₹4.67 Cr bought
Wednesday 19 May 20211 firm · ₹5.53 Cr bought · ₹5.54 Cr soldNet sold ₹54,770
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 6,08,550 at ₹90.88Sold 6,08,550 at ₹90.970.66% of the companyNet nil₹5.53 Cr bought
Thursday 6 May 20214 firms · ₹29 Cr bought · ₹30 Cr soldNet sold ₹0.05 Cr
- Both waysXTX MARKETS LLPBought 5,89,560 at ₹90.41Sold 5,93,161 at ₹90.500.65% of the companyNet −3,601 shares₹5.33 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 13,58,056 at ₹91.02Sold 13,58,056 at ₹91.091.48% of the companyNet nil₹12 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 6,57,703 at ₹90.76Sold 6,57,703 at ₹90.830.72% of the companyNet nil₹5.97 Cr bought
- Both waysQE SECURITIESBought 6,38,265 at ₹91.21Sold 6,38,303 at ₹91.250.70% of the companyNet −38 shares₹5.82 Cr bought
Wednesday 5 May 20212 firms · ₹8.25 Cr bought · ₹5.99 Cr soldNet bought ₹2.26 Cr
- Both waysNAVY RAMAVAT (HUF)Bought 5,15,104 at ₹82.88Sold 2,41,355 at ₹82.880.56% of the companyNet +2,73,749 shares₹4.27 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 5,14,253 at ₹77.46Sold 5,14,253 at ₹77.590.56% of the companyNet nil₹3.98 Cr bought
Wednesday 9 Dec 20202 firms · ₹3.37 Cr bought · ₹6.31 Cr soldNet sold ₹2.95 Cr
- Both waysGYANSHANKAR INVESTMENTS AND TRADING COMPANY PRIVATE LIMITEDBought 22,165 at ₹64.94Sold 4,67,953 at ₹65.980.51% of the companyNet −4,45,788 shares₹0.14 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 4,87,090 at ₹66.13Sold 4,87,090 at ₹66.250.53% of the companyNet nil₹3.22 Cr bought
Thursday 18 Mar 20102 firms · ₹9.17 Cr bought · ₹9.16 Cr soldNet bought ₹61,546
- BoughtAPOLLO HOSPITALS ENTERPRISE LTDBought 19,74,183 at ₹46.44₹9.17 Cr
- SoldUNIQUE HOME HEALTH CARE LTDSold 19,72,433 at ₹46.45₹9.16 Cr
Friday 5 Dec 20081 firm · ₹0 bought · ₹1.87 Cr soldNet sold ₹1.87 Cr
- SoldREESHANAR INVESTMENTS LTDSold 7,47,905 at ₹25.00₹1.87 Cr
Friday 19 Aug 20051 firm · ₹0 bought · ₹3.57 Cr soldNet sold ₹3.57 Cr
- SoldTWL HOLDINGS LIMITEDSold 7,74,780 at ₹46.13₹3.57 Cr
Monday 14 Feb 20051 firm · ₹1.80 Cr bought · ₹0 soldNet bought ₹1.80 Cr
- BoughtUNION INVESTMENT LUXEMBOUR S.A.Bought 4,93,020 at ₹36.61₹1.80 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 33 deals on record from 4 Jan 2004.